102 related articles for article (PubMed ID: 12586333)
21. Differential effect of activin A and BMP-7 on myofibroblast differentiation and the role of the Smad signaling pathway.
You L; Kruse FE
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):72-81. PubMed ID: 11773015
[TBL] [Abstract][Full Text] [Related]
22. TGF-beta1 increases tyrosine hydroxylase expression by a mechanism blocked by BMP-2 in human neuroblastoma SH-SY5Y cells.
Gómez-Santos C; Ambrosio S; Ventura F; Ferrer I; Reiriz J
Brain Res; 2002 Dec; 958(1):152-60. PubMed ID: 12468040
[TBL] [Abstract][Full Text] [Related]
23. Integration of IGF, FGF, and anti-BMP signals via Smad1 phosphorylation in neural induction.
Pera EM; Ikeda A; Eivers E; De Robertis EM
Genes Dev; 2003 Dec; 17(24):3023-8. PubMed ID: 14701872
[TBL] [Abstract][Full Text] [Related]
24. Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and induces osteoblast differentiation in C2C12 myoblasts.
Yamamoto N; Akiyama S; Katagiri T; Namiki M; Kurokawa T; Suda T
Biochem Biophys Res Commun; 1997 Sep; 238(2):574-80. PubMed ID: 9299554
[TBL] [Abstract][Full Text] [Related]
25. Activation of the bone morphogenetic protein signaling pathway induces inhibin beta(B)-subunit mRNA and secreted inhibin B levels in cultured human granulosa-luteal cells.
Jaatinen R; Bondestam J; Raivio T; Hildén K; Dunkel L; Groome N; Ritvos O
J Clin Endocrinol Metab; 2002 Mar; 87(3):1254-61. PubMed ID: 11889196
[TBL] [Abstract][Full Text] [Related]
26. Signaling by bone morphogenetic proteins and Smad1 modulates the postnatal differentiation of cerebellar cells.
Angley C; Kumar M; Dinsio KJ; Hall AK; Siegel RE
J Neurosci; 2003 Jan; 23(1):260-8. PubMed ID: 12514223
[TBL] [Abstract][Full Text] [Related]
27. Induction of Olig2 precursors by FGF involves BMP signalling blockade at the Smad level.
Bilican B; Fiore-Heriche C; Compston A; Allen ND; Chandran S
PLoS One; 2008 Aug; 3(8):e2863. PubMed ID: 18682850
[TBL] [Abstract][Full Text] [Related]
28. The bone morphogenetic protein 2 signaling mediator Smad1 participates predominantly in osteogenic and not in chondrogenic differentiation in mesenchymal progenitors C3H10T1/2.
Ju W; Hoffmann A; Verschueren K; Tylzanowski P; Kaps C; Gross G; Huylebroeck D
J Bone Miner Res; 2000 Oct; 15(10):1889-99. PubMed ID: 11028440
[TBL] [Abstract][Full Text] [Related]
29. Role of TAK1 and TAB1 in BMP signaling in early Xenopus development.
Shibuya H; Iwata H; Masuyama N; Gotoh Y; Yamaguchi K; Irie K; Matsumoto K; Nishida E; Ueno N
EMBO J; 1998 Feb; 17(4):1019-28. PubMed ID: 9463380
[TBL] [Abstract][Full Text] [Related]
30. Blocked MAP kinase activity selectively enhances neurotrophic growth responses.
Althini S; Usoskin D; Kylberg A; Kaplan PL; Ebendal T
Mol Cell Neurosci; 2004 Feb; 25(2):345-54. PubMed ID: 15019950
[TBL] [Abstract][Full Text] [Related]
31. Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads.
Itoh F; Asao H; Sugamura K; Heldin CH; ten Dijke P; Itoh S
EMBO J; 2001 Aug; 20(15):4132-42. PubMed ID: 11483516
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the bone morphogenetic protein-2 as a neurotrophic factor. Induction of neuronal differentiation of PC12 cells in the absence of mitogen-activated protein kinase activation.
Iwasaki S; Hattori A; Sato M; Tsujimoto M; Kohno M
J Biol Chem; 1996 Jul; 271(29):17360-5. PubMed ID: 8663261
[TBL] [Abstract][Full Text] [Related]
33. Effects of FGF-2/-9 in calvarial bone cell cultures: differentiation stage-dependent mitogenic effect, inverse regulation of BMP-2 and noggin, and enhancement of osteogenic potential.
Fakhry A; Ratisoontorn C; Vedhachalam C; Salhab I; Koyama E; Leboy P; Pacifici M; Kirschner RE; Nah HD
Bone; 2005 Feb; 36(2):254-66. PubMed ID: 15780951
[TBL] [Abstract][Full Text] [Related]
34. Characterization of a bone morphogenetic protein-responsive Smad-binding element.
Kusanagi K; Inoue H; Ishidou Y; Mishima HK; Kawabata M; Miyazono K
Mol Biol Cell; 2000 Feb; 11(2):555-65. PubMed ID: 10679014
[TBL] [Abstract][Full Text] [Related]
35. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
36. Negative regulation of BMP signaling by the ski oncoprotein.
Luo K
J Bone Joint Surg Am; 2003; 85-A Suppl 3():39-43. PubMed ID: 12925608
[TBL] [Abstract][Full Text] [Related]
37. Functional relationship between fibroblast growth factor-8 and bone morphogenetic proteins in regulating steroidogenesis by rat granulosa cells.
Miyoshi T; Otsuka F; Yamashita M; Inagaki K; Nakamura E; Tsukamoto N; Takeda M; Suzuki J; Makino H
Mol Cell Endocrinol; 2010 Aug; 325(1-2):84-92. PubMed ID: 20434519
[TBL] [Abstract][Full Text] [Related]
38. Repulsive guidance molecule (RGMa), a DRAGON homologue, is a bone morphogenetic protein co-receptor.
Babitt JL; Zhang Y; Samad TA; Xia Y; Tang J; Campagna JA; Schneyer AL; Woolf CJ; Lin HY
J Biol Chem; 2005 Aug; 280(33):29820-7. PubMed ID: 15975920
[TBL] [Abstract][Full Text] [Related]
39. Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension.
Yang X; Long L; Southwood M; Rudarakanchana N; Upton PD; Jeffery TK; Atkinson C; Chen H; Trembath RC; Morrell NW
Circ Res; 2005 May; 96(10):1053-63. PubMed ID: 15845886
[TBL] [Abstract][Full Text] [Related]
40. The effects of bone morphogenetic protein and basic fibroblast growth factor on cultured mesenchymal stem cells for spine fusion.
Minamide A; Yoshida M; Kawakami M; Okada M; Enyo Y; Hashizume H; Boden SD
Spine (Phila Pa 1976); 2007 May; 32(10):1067-71. PubMed ID: 17471086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
